IDiyas

For the Inventor, By the Inventor

Vence, France

Sandrine Talano

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 4.2

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal7 out of 222 
 
Galderma Research & Development
 patents

Years Active: 2010-2015

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents
1. 8993596 - 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics (2015-03-31),
2. 8697726 - 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics (2014-04-15),
3. 8470871 - Ligands that modulate RAR receptors (2013-06-25),
4. 8299259 - 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics (2012-10-30),
5. 8227507 - Ligands that modulate RAR receptors (2012-07-24),
6. 8119674 - 4-phenylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof (2012-02-21),
7. 7807708 - Ligands that modulate RAR receptors and pharmaceutical/cosmetic compositions comprised thereof (2010-10-05),

Title: Innovations of Sandrine Talano

Introduction

Sandrine Talano is a notable inventor based in Vence, France. She has made significant contributions to the field of medicine and cosmetics through her innovative research and development efforts. With a total of seven patents to her name, her work focuses on compounds that have the potential to treat various pigmentary disorders.

Latest Patents

Among her latest patents are the 4-(azacycloalkyl)benzene-1,3-diol compounds, which serve as tyrosinase inhibitors. These compounds are described in detail, corresponding to a specific general formula. The patents also outline processes for the preparation of these compounds and their applications in human medicine and cosmetics. The compositions derived from these compounds are aimed at treating pigmentary disorders, showcasing her commitment to advancing healthcare solutions.

Career Highlights

Sandrine Talano is currently associated with Galderma Research & Development, where she continues to innovate and contribute to the field. Her work has garnered attention for its potential impact on both pharmaceutical and cosmetic industries.

Collaborations

She collaborates with esteemed colleagues, including Jean-Guy Boiteau and Corinne Millois Barbuis, who contribute to her research endeavors.

Conclusion

Sandrine Talano's innovative work in developing tyrosinase inhibitors highlights her significant role in advancing treatments for pigmentary disorders. Her contributions to Galderma Research & Development and her impressive patent portfolio underscore her impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…